These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 20025444)

  • 1. Can drug users be effective change agents? Yes, but much still needs to change.
    Dickson-Gomez J
    Subst Use Misuse; 2010; 45(1-2):154-60. PubMed ID: 20025444
    [No Abstract]   [Full Text] [Related]  

  • 2. [Relapse prevention in drug addicts].
    Rácz J
    Neuropsychopharmacol Hung; 2013 Dec; 15(4):232-8. PubMed ID: 24380964
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The social logic of naloxone: Peer administration, harm reduction, and the transformation of social policy.
    Faulkner-Gurstein R
    Soc Sci Med; 2017 May; 180():20-27. PubMed ID: 28315595
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A critical narrative inquiry to understand the impacts of an overdose prevention site on the lives of site users.
    Oudshoorn A; Sangster Bouck M; McCann M; Zendo S; Berman H; Banninga J; Le Ber MJ; Zendo Z
    Harm Reduct J; 2021 Jan; 18(1):6. PubMed ID: 33407553
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A social network approach to demonstrate the diffusion and change process of intervention from peer health advocates to the drug using community.
    Li J; Weeks MR; Borgatti SP; Clair S; Dickson-Gomez J
    Subst Use Misuse; 2012 Apr; 47(5):474-90. PubMed ID: 22428816
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Harm Reduction Services in Ottawa: The Culture of Drug Use.
    Haines M; O'Byrne P
    Res Theory Nurs Pract; 2020 May; 34(2):188-202. PubMed ID: 32457123
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Street-level research on street-level interventions among drug users: commentary on papers by Frank et al., Hayashi et al., Small et al., and Domanico and Malta.
    Lune H
    Subst Use Misuse; 2012 Apr; 47(5):555-7. PubMed ID: 22428823
    [No Abstract]   [Full Text] [Related]  

  • 8. Optimal timing of use reduction vs. harm reduction in a drug epidemic model.
    Caulkins JP; Tragler G; Wallner D
    Int J Drug Policy; 2009 Nov; 20(6):480-7. PubMed ID: 19361975
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Harm reduction interventions in drug users: current situation and recommendations].
    Bosque-Prous M; Brugal MT
    Gac Sanit; 2016 Nov; 30 Suppl 1():99-105. PubMed ID: 27837802
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fatal and non-fatal overdose among opiate users in South Wales: A qualitative study of peer responses.
    Holloway K; Hills R; May T
    Int J Drug Policy; 2018 Jun; 56():56-63. PubMed ID: 29605706
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Implementation of harm reduction toward crack users in Brazil: barriers and achievements.
    Domanico A; Malta M
    Subst Use Misuse; 2012 Apr; 47(5):535-46. PubMed ID: 22428821
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Harm reduction behaviors among young polysubstance users at raves.
    Fernández-Calderón F; Lozano-Rojas Ó; Rojas-Tejada A; Bilbao-Acedos I; Vidal-Giné C; Vergara-Moragues E; González-Saiz F
    Subst Abus; 2014; 35(1):45-50. PubMed ID: 24588292
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Defining a service for people who use drugs as 'low-threshold': what should be the criteria?
    Mofizul Islam M; Topp L; Conigrave KM; Day CA
    Int J Drug Policy; 2013 May; 24(3):220-2. PubMed ID: 23567101
    [No Abstract]   [Full Text] [Related]  

  • 14. 'Towards a global approach'--an overview of Harm Reduction 2008: IHRA's 19th International Conference.
    Fraser S; Hopwood M; Madden A; Treloar C
    Int J Drug Policy; 2009 Jan; 20(1):93-7. PubMed ID: 18835148
    [No Abstract]   [Full Text] [Related]  

  • 15. Programs that incorporate active drug users as change agents for promoting their own goals and those of public health. Preface.
    Latkin C; Friedman SR
    Subst Use Misuse; 2012 Apr; 47(5):461. PubMed ID: 22428814
    [No Abstract]   [Full Text] [Related]  

  • 16. Participatory research with an online drug forum: a survey of user characteristics, information sharing, and harm reduction views.
    Chiauzzi E; Dasmahapatra P; Lobo K; Barratt MJ
    Subst Use Misuse; 2013 Jun; 48(8):661-70. PubMed ID: 23750771
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The impact of human rights violations and perceptions of discrimination on health service utilization among injection drug users in Delhi, India.
    Sarin E; Kerrigan D
    Subst Use Misuse; 2012 Feb; 47(3):230-43. PubMed ID: 22217124
    [TBL] [Abstract][Full Text] [Related]  

  • 18. "Who has ever loved a drug addict? It's a lie. They think a 'teja' is as bad person": multiple stigmas faced by women who inject drugs in coastal Kenya.
    Mburu G; Ayon S; Tsai AC; Ndimbii J; Wang B; Strathdee S; Seeley J
    Harm Reduct J; 2018 May; 15(1):29. PubMed ID: 29801494
    [TBL] [Abstract][Full Text] [Related]  

  • 19. "It's not rocket science, what I do": Self-directed harm reduction strategies among drug using ethno-racially diverse gay and bisexual men.
    Greenspan NR; Aguinaldo JP; Husbands W; Murray J; Ho P; Sutdhibhasilp N; Cedano J; Lau C; Gray T; Maharaj R
    Int J Drug Policy; 2011 Jan; 22(1):56-62. PubMed ID: 20952176
    [TBL] [Abstract][Full Text] [Related]  

  • 20. "They accept me, because I was one of them": formative qualitative research supporting the feasibility of peer-led outreach for people who use drugs in Dakar, Senegal.
    Stengel CM; Mane F; Guise A; Pouye M; Sigrist M; Rhodes T
    Harm Reduct J; 2018 Feb; 15(1):9. PubMed ID: 29486774
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.